CD274 and neoplasm: The PD-L1 tumor proportion score (TPS) is the ratio between PD-L1-positive tumor cells and all tumor cells in the respective sample; high TP scores are associated with better response to immune checkpoint inhibitors targeting PD-1 or PD-L1 and higher overall survival in NSCLC patients [29,30].